Abbreviations used: BBB, blood-brain barrier; CT, com puter-assisted transverse axial tomography; EDTA, ethylenedi aminetetraacetic acid; 10 M, inferior orbitomeatal; PET, posi tron emission tomography.
Summary: Positron emission tomography with [68Galeth ylenediaminetetraacetic acid ([68GalEDTA) was used to examine the integrity of the blood-brain barrier (BBB) in five patients with dementia of the Alzheimer type and in five healthy age-matched controls. Within a scanning time of 90 min, there was no evidence that measurable intravascular tracer entered the brain in either the de mentia or the control group. An upper limit for the cere-
The blood-brain barrier (BBB) is due to a con tinuous layer of endothelial cells that line cerebral blood vessels and that are connected by tight junc tions (zonulae occludens) (Reese and Karnovsky, 1967; Rapoport, 1976) . The tight junctions limit in terendothelial diffusion of blood-borne ions, water soluble nonelectrolytes, and proteins into the brain and contribute to the immune privilege of the cen tral nervous system (Rapoport, 1976) .
The extracellular space of postmortem brain tissue from patients with Alzheimer's disease has been reported to be flooded with serum albumin, which is absent in control brain tissue (Wisniewski and Koslowski, 1982) , suggesting that breakdown of the BBB is pathogenic in Alzheimer's disease. Furthermore, histological techniques demonstrate serum immunoglobulin components within neuritic plaques in brains of patients with Alzheimer's dis ease, suggesting that BBB breakdown in Alz-1 brovascular permeability-surface area product of [68GalEDTA was estimated as 2 x 10-6 S-1 in both groups. The results provide no evidence for breakdown of the BBB in patients with dementia of the Alzheimer type. Key Words: Alzheimer's disease-Blood-brain barrier-[68GalEthylenediaminetetraacetic acid -Per meability -Positron emission tomography.
heimer's disease is related to immunologically me diated brain injury (Ishii et aI. , 1975; Raga, 1976, 1984; Mann et aI. , 1982; Eikelenboom and Starn, 1984) .
A site of BBB breakdown might be cerebral vessels that contain amyloid and demonstrate con gophilic angiopathy (Glenner et aI. , 1981; Eikelen boom and Starn, 1984) . The incidence of congo philic angiopathy in brains from patients with Alz heimer's disease has been reported to equal 89% (Glenner et aI. , 1981) . Consistent with this hy pothesis is the report that antibrain antibodies are elevated in sera of patients with Alzheimer's dis ease (Nandy, 1978) .
We recently demonstrated that positron emission tomography (PET), using [68Ga]ethylenediamine tetraacetic acid ([68Ga]EDTA) as a positron-emitting tracer, could be employed to examine BBB integ rity in monkeys following reversible BBB modifica tion by intracarotid infusion of a hypertonic man nitol solution (Kessler et aI. , 1984) . The tracer was injected intravenously as a bolus, and time-depen dent values for the cerebral capillary permeability surface area product PA were calculated according to the method of Ohno et al. (1978) , by relating re gional brain radioactivity (corrected for intravas cular radioactivity) to the time course of plasma ra dioactivity.
The intravenous bolus method also has been em-ployed with PET to examine BBB integrity in humans using [68Ga]EDTA or 82Rb. The BBB has been shown to be altered in patients with cerebral infarction as well as in patients with primary and metastatic brain tumors (Ericson et aI. , 1981; Hawkins et aI. , 1984a,b; Ilsen et aI. , 1984; Jarden et aI. , 1984 Jarden et aI. , , 1985 Wong et aI. , 1984; Wapenski et aI., 1985) . Friedland et ai. (1983 Friedland et ai. ( , 1985a could not demonstrate disruption of the BBB in patients with dementia of the Alzheimer type when using 82Rb or [68Ga]EDTA. These investigators did not also ex amine control subjects, so the limits of their anal ysis were not established.
As the role of the BBB in Alzheimer's disease has not been resolved, we thought it of interest to examine BBB integrity in patients with dementia of the Alzheimer type as well as in healthy controls, when using the sensitive intravenous bolus method of Ohno et ai. (1978) and PET. Furthermore, we also wanted to estimate, if possible, an upper limit for PA to [68GaJEDTA in these two groups of sub jects.
METHODS

Patient selection
Five healthy male control subjects between the ages of 56 and 79 years were studied. They were participants in a clinical program on Brain Metabolism and Aging con ducted by the Laboratory of Neurosciences of the Na tional Institute on Aging, and had been screened to ex clude major medical, neurologic, and psychiatric disease (Duara et aI., 1983) .
In addition, we studied five male patients with de mentia of the Alzheimer type diagnosed according to the Diagnostic and Statistical Manual for Mental Disorders (3rd ed.) (American Psychiatric Association, 1980) . Their ages ranged from 53 to 78 years. These patients under went screening identical to that of the controls and were free of major medical disease except for dementia of the Alzheimer type. Patients as well as controls were sub jected to computer-assisted transverse axial tomography (CT) of the brain, without contrast enhancement. The pa tients also were administered the Mini-Mental Status Ex amination (Folstein et aI., 1975) and the Mattis Dementia Scale (Mattis, 1976) to assess the severity of their de mentia. Four patients with dementia of the Alzheimer type were off medication for at least 2 weeks prior to the scan; one was on a low dose of the dopaminergic antago nist haloperidol (0.5 mg t.i.d.).
Patients and controls signed an informed consent that described the purpose and procedure of this study as well as the risks involved. The guardians of the patients with dementia also signed the consent form.
PET scanning 68Ga was eluted from an ionic 68Ge/68Ga generator (New England Nuclear, North Billerica, MA, U.S.A.) with 1 N HCI. EDTA was added to the eluate and the reaction mixture was neutralized with NazC03 to pH J Cereb Blood Flow Metab, Vol. 7, No.1, 1987 6.8-7 .0. All samples were tested for endotoxins and ste rility.
PET scanning was performed with an ECAT II positron emission tomograph (ORTEC, Life Sciences, Oak Ridge, TN, U.S.A.) in the medium-resolution mode (full width at half-maximum 1.7 x 1.7 cm), with standard shadow shields and a medium-resolution reconstruction filter. Scans were performed between 09:00 and 12:00 h. Each subject had catheters inserted into a radial artery and into the antecubital vein of the opposite arm. He then was positioned in the PET scanner so that a single horizontal scan could be obtained parallel to and at 70 mm above the inferior orbitomeatal (10M) line. Ambient light was re duced but the subject was not blindfolded nor were his ears plugged. Arterial blood was drawn prior to each scan for determination of blood gases and pH. Vital signs were obtained before and after each scan.
Scanning was begun at the time of intravenous injec tion of 2.5 or 5 mCi of [68Ga]EDTA as a bolus. Five I-min scans were obtained during the first 5 min postinjection, followed by consecutive 5-min scans during the next 85 min, for a total of 22 scans. To tal scanning time equaled 90 min.
Arterial blood samples (1 m!) were obtained at 30, 45, 60, 75, 90, 105, and 120 s postinjection, as well as at 3,4, 5,6,8,10,15, and 20 min, and then every 10 min until the end of scanning. The blood was centrifuged and 300-"d aliquots of plasma were removed for measurement of ra dioactivity (Gamma 8000 counting system; Beckman In struments, Fullerton, CA, U.S.A.).
Phantoms that contained known radioactivities also were scanned to calibrate tissue radioactivity in counts per minute. Attenuation correction was performed by a calculation algorithm using an operator-fitted ellipse made available by ORTEC.
Data analysis
Regions of interest were defined when comparing PET images to horizontal brain sections, at 70 mm above and parallel to the 10M line, as illustrated in a standard atlas (Eycleshymer and Schoemaker, 1911) . Regions of in terest (average area 30 cmZ) were chosen within central portions of the left and right hemispheres to minimize scatter from skull radioactivity and to exclude identifi able vascular structures. Curves relating brain radioac tivity to time after intravenous injection of [68Ga]EDTA were constructed for each region of interest. Owing to counting limitations, the data were quite noisy (see Re sults). All radioactivities were decay-corrected for the tv, of 68Ga equal to 68.3 min.
The curves were analyzed by two models. The first as sumes that tissue activity is due entirely to intravascular tracer and that no tracer enters brain tissue, whereas the second allows for tracer entry into brain. In either case, brain radioactivity obtained during the ith scan, between ti and ti + I , is given as Qi (cpm g-I) after correction for a tissue density of 1.04 (Livingston, 1955) . The equation for the first model is
where C (t) is the plasma concentration (cpm ml-I) at time t and Vp is the plasma volume (ml g-I) in the region of interest. This model has one parameter, Vp, that can be estimated by linear regression from the relation between tissue radioactivity and time. A continuous curve relating plasma radioactivity to time was constructed by linear in terpolation of measured values between sample times. The second model allows for tracer extraction by brain. The extravascular space is taken as a single com partment with influx constant kl [ml g-I s -l or s -I as brain specific gravity approximates 1 (Livingston, 1955) ]. The change in brain concentration with time is given as follows (Rapoport et ai., 1980; Kessler et aI., 1984) :
( 2) where Vd is the tissue distribution volume of [68Ga]EDTA. The clearance rate coefficient for back dif fusion equals kl/Vd in Eq. 2. For curve fitting, Vd was fixed at 0.15 ml g-I, the average extracellular distribution volume of cerebral tissue (Fenstermacher and Rapoport, 1984) . Qi , the incremental brain radioactivity in the ith scan (Eq. 1), is given in terms of two parameters, plasma volume Vp and the influx rate constant kl, for an assumed value of Vd:
( 3) where * represents the convolution operator. For simple capillary exchange (Renkin, 1959; Crone, 1963; Rapo port, 1976) , kl can be expressed as follows:
where F is regional cerebral blood flow and PAis the capillary permeability-surface area product (s -I for both). For PA « F, kl approximates PA , which applies in this study because P A for [68Ga]EDTA normally ap proximates � 10 -5 S -1 and F has a value of 10 -2 S -I in the human brain (Siesjb, 1978; Kessler et ai., 1984) . Nonlinear curve fitting was performed using the BLD modeling and analysis software (Carson et aI., 1981) . For each curve estimates of the parameters and of their stan dard errors were tabulated, as well as confidence in tervals (mean ± 2 SE). Comparison of the residual sum of squares of the two models was performed using the F test (Beck and Arnold, 1977) to determine if kl differed significantly from 0 (p < 0.05).
We analyzed tissue radioactivity graphically by the method of Patlak et ai. (1983) , which assumes a general compartment model having mUltiple exchangeable com partments and one irreversible compartment. After a suitable equilibration time t*, the following relation ap plies:
where K is the steady-state rate constant of binding into the irreversible compartment and Ve is the distribution volume of the exchangeable space including the vascular space. Plotting the distribution volume Q(t)/Cp(t) versus transformed time fbCp(s)ds/C/t) after t* should yield a linear relation with slope K and intercept Ve' This ap proach produced noisy curves because of count limita tions (see Results). Therefore, a new relation was derived by integrating Eq. 5 from 0 to t and dividing by fbCp(s)ds, yielding LQ(S)dS LCp(S)dS (6) The term on the left-hand side has dimensionless units of distribution volume. The ratio of the double integral of Cp to the single integral of Cp has units of time. Plotting the integrated distribution volume versus transformed time should yield a linear relation with slope K. By integrating tissue radioactivity, the noise in the curve is reduced sig nificantly.
Note that the single-compartment model of Eqs. 2 and 3 allows for tracer clearance from the tissue compart ment, which is inconsistent with the assumptions of Eqs. 5 and 6. If a significant amount of tracer is cleared from the tissue space (which assumes there is significant tracer extraction in the first place), this will produce a nonlin earity in the transformed plots. However, at early times, before tracer clearance has become significant, the linear relation of Eq. 6 will be valid.
RESULTS
Two patients with dementia of the Alzheimer type had Mini-Mental Examination scores of 22 and 26 (mild dementia) and corresponding Mattis De mentia Scale scores of 125 and 131. CT scans of the brain indicated mild and moderate cortical atrophy. The remaining three patients had Mini-Mental scores of 10, 11, and 12 (severe to moderate de mentia) and Mattis scores of 100, 89, and 54, re spectively. Their CT scans indicated moderate (one case) and diffuse (two cases) cortical atrophy, with calcification of the basal ganglia and dentate nu cleus in the scan of the 78-year-old patient. There was no focal lesion suggestive of multiple infarct dementia, tumor, or other focal abnormality in any CT scan. CT scans of the controls were within normal limits when compared with those of a more extended group of age-matched controls (Schwartz et aI. , 1985) .
Ta ble 1 summarizes physiological data on the control subjects and patients with dementia of the Alzheimer type. There were no statistically signifi cant differences (p > 0. 05) between means of the two groups for any of the variables in the table.
PET scans with [68Ga]EDTA are illustrated in Fig. 1 for a control subject and a patient with de mentia of the Alzheimer type at 70 mm above the 10M line. Comparison of the scans to an atlas of Values are means ± SD, n = 5.
coronal sections of the human brain (Eycleshymer and Schoemaker, 1911) shows that regions dis played are chiefly in the parietal and frontal lobes, which are known to demonstrate marked neuropa thology and altered glucose metabolism in Alz heimer's disease (Haxby et aI. , 1985; Pearson et aI. , 1985) . The PET images were obtained 60 min after intravenous injection of the radiotracer and show minimal brain uptake of [68Ga]EDTA. The outer ring of optical density represents radioactivity within the skull. A typical plasma activity-time curve, following the intravenous injection of 5 mCi of [68Ga]EDTA in a control subject, is depicted in Fig. 2A . Using the plasma input function for each subject, the left and right hemisphere region-of-interest tissue ra dioactivity curves for the subject were fit to Eqs. 1 and 3. An example of a hemispheric region-of-in terest curve for the control subject of Fig. 2A is il lustrated in Fig. 2B .
Typical 5-min scans at 60 min after injection of 2. 5 or 5 mCi [68Ga]EDTA had only 15, 000-30, 000 counts. Even for the large regions of interest used here (surface area � 30 cm2), coefficients of varia- tion (SD/mean) of brain radioactivities ranged from 35 to 50%.
In only 1 of the 20 analyses did the two-compart ment model (model 2) provide a significantly better fit to the data than the one-compartment model (model 1) (p < 0. 05, F test). Therefore, the hy pothesis that tracer was not extracted by brain, i. e. , that kJ = 0, cannot be rejected. The fit using model and of the tracer influx rate constant k1' with ap propriate standard errors that define the upper limit for k1 at each region of interest at p < 0.05. The data are summarized in Ta ble 2, which shows that there were no statistically significant differences between patients with dementia of the Alzheimer type and controls with respect to plasma volume and k) and that the upper bound for k) approxi mated 2 x 10 -6 S -I . The standard errors in Ta ble 2, which are used to derive a confidence interval and an upper bound for each parameter, were estimated from nonlinear curve fitting and are approximate (Carson et aI. , 1981) . Two other model equations were fitted to the data, one with clearance fixed at zero (no back dif fusion) and the other with a free-floating clearance parameter. The latter has been used for fitting [68Ga]EDTA activity-time curves from tumor data (Blasberg et aI. , 1984; Hawkins et aI. , 1984a,b) . Neither fit provided a statistically significant im provement over the two-compartment fit with a fixed brain distribution volume as measured by the F test (p > 0. 05). Figure 3 displays sample curves relating inte grated brain distribution volumes of [68Ga]EDTA to transformed time according to Eq. 6. The curves were obtained from a patient with dementia of the Alzheimer type and a control subject whose param eter estimates best matched the respective group means. As noted in Methods, plots of Q(t)/Cp(t) against transformed time, according to Eq. 5, pro duced noisy curves owing to the large coefficient of variation of Q(t) (see above) and were not useful.
On the other hand, plotting the integrated distribu tion volume against time produced the smooth curves illustrated in Fig. 3 . The curves did not have statistically significant regression coefficients (p > 0. 05) and therefore did not provide a k) distinguish able from zero. Distribution volumes at all trans formed times were equivalent to the extrapolated zero-time value, which can be taken as plasma volume Vp. Values are means ± SD, n = 5. Data from the two h � mi spheres were combined for each subject. There were no statIstI cally significant differences between groups (p > 0.05).
a Upper bound defined as k l + 2 SE.
DISCUSSION
This study provides no evidence for increased permeability of the BBB in dementia of the Alz heimer type. Over a scanning period of 90 min fol lowing the intravenous injection of [68Ga]EDTA, the distribution volume for tracer, defined as tissue concentration divided by plasma concentration, showed no relation to time of scanning, indicating that tracer could not be detected within the brain compartment. Furthermore, by nonlinear curve fit ting of data, using an equation for two brain com partments (blood and brain), values for k) (unidi rectional transfer constant for tracer from blood to brain) were derived that did not differ significantly from zero (p > 0. 05).
The upper bound for k) did not exceed 2 x 10-6 S -) whereas cerebral blood flow F equals 10 -2 s-) in humans (Siesjo, 1978) . Inserting these values into Eq. 4 shows that in this study k) can be taken as identical to the brain capillary permeability-sur face area product PA. The estimate for the upper bound on k) approximates the value of PA of [68Ga]EDTA in monkeys, < 10-5 S-1 (Kessler et aI. , 1984) , and is of the order of PA for [5)Cr]EDTA in rats, equal to 4.5 x 10-6 S-I (Sorensen, 1974; Fen stermacher and Rapoport, 1984) . More sensitive procedures would be required to experimentally determine a nonzero value for PA that is < 10 -5 S -). This might be possible with a higher dose of [68Ga]EDTA, a more efficient scanner, and a duration of study beyond 90 min. For example, with the input plasma radioactivity in Fig. 2A , a control Vb of 0. 018 ml g-), and a kl of 1. 2 x 10 -6 s -) at 90 min after intravenous injection of tracer, only 40% of net tissue activity would be within the brain parenchyma. Were it possible to wait until more tracer were eliminated from blood, the error due to intravascular tracer would be re duced. For example, to demonstrate a measurable PA for [I4C]inulin, equal to 2 x 10 -7 S -), experi ments in rats that last longer than 180 min after in travenous injection of tracer are required (Ohno et aI. , 1978) .
Additional factors might have affected our re sults. Parameter estimates depend on the anatom ical level being scanned because of different mix tures of gray and white matter. Another factor is scatter. Without an accurate scatter correction al gorithm, some portion of measured brain activity will be caused by scatter from the high level of ra dioactivity in the skull. We did not correct for scatter, but it was minimized because of the large detector separation (100 cm) of the EC AT II and because we used medium-resolution shadow shields. TRANSFORMED TIME (min)
The use of large regions of interest placed in the center of the hemispheres is another factor to be considered. Measurements of smaller regions could have been used. However, accurate kJ measure ments for small regions of interest were beyond the sensitivity of the method owing to scatter and count limitations. Corrections for cortical atrophy also could have been applied (Herscovitch et aI. , 1986; Schlageter et aI. , 1986 ), but should not have af fected the results in view of the lack of measurable brain uptake of radioactivity.
Our conclusion that BBB permeability is not ele vated in dementia of the Alzheimer type agrees with that of Friedland et al. (1983 Friedland et al. ( , 1985a , but is, we believe, more reliable, because our input func tion was arterial rather than venous blood and, more importantly, we examined control subjects as well as patients with dementia. Use of controls pro vides estimates of the validity of the methods and of the limits of the analytical procedures employed.
Our finding of an intact BBB in dementia of the Alzheimer type disagrees with histological and im munocytochemical evidence that the BBB is broken down in Alzheimer's disease. Serum al bumin has been reported to be diffusely distributed within brains of Alzheimer's disease patients, and immunoglobulins are found in senile (neuritic) plaques of such brains (Ishii and Haga, 1976; Mann et aI. , 1982; Wisniewski and Kozlowski, 1982) . Fur thermore, congophilic angiopathy, accompanied by amyloid in the cerebral vasculature, may be asso ciated with altered cerebrovascular permeability in Alzheimer's disease (N andy, 1978; Glenner et aI. , 1981) . Finally, excess quantities of aluminum, which is of vascular origin, have been reported in the senile plaques of patients with Alzheimer's dis ease (Edwardson et aI. , 1985) . These findings sug-J Cereb Blood Flow Metab, Vol. 7, No.1, 1987 40 50 gest at least local and transient alterations of BBB integrity in Alzheimer's disease. As noted above, our methods may not be suffi ciently sensitive to identify BBB breakdown that occurs transiently or at isolated intracerebral sites. Nevertheless, our findings are not inconsistent with the lack of reports of brain edema in patients with dementia of the Alzheimer type. In other experi mental and clinical conditions, BBB breakdown is associated with brain edema (Rapoport, 1976 (Rapoport, , 1978 Klatzo et aI. , 1980) . The edema is ascribed to entry of normally excluded plasma protein into the brain extracellular space, altering oncotic forces across the cerebral vasculature, as well as to loss of BBB integrity to small plasma solutes of the size of [68Ga]EDTA, such as Na + and Cl-, resulting in un balanced hydrostatic forces across the vasculature .
Our findings also are consistent with our obser vation that plasma albumin and globulin are not found in abnormal quantities in the CSF of patients with dementia of the Alzheimer type as compared with age-matched controls (Kay et aI. , 1986) . With the massive albumin extravasation reported by Wisniewski and Kozlowski (1982) in brains of pa tients with Alzheimer's disease, excess CSF/serum ratios of albumin and of immunoglobulin G would be expected.
